INS and cancer: Nrf2 is a key transcription factor that binds to the antioxidant response element (ARE) in response to environmental carcinogens or low levels of insulin, and increases the transcription of a variety of antioxidative and carcinogen-detoxification enzymes that boost protection against cellular and molecular damage and cancer [14-16].